Lung cancer is the leading cause of cancer mortality worldwide. Dendritic cells (DCs) are the
key factors providing protective immunity against lung tumors and clinical trials have proven …

Over the past ten years, the identification of the critical role that dendritic cells (DCs) play in
stimulating a specific immune response has led to their use in cancer and HIV therapy …

Natural tumor surveillance capabilities of the host were investigated in six different mouse
tumor models where endogenous interleukin (IL)-12 does or does not dictate the efficiency …

Flt3 ligand (Flt3L) is a growth factor for hemopoietic progenitors and can promote the
expansion of both conventional dendritic cells (DCs) and plasmacytoid predendritic cells (p …

Dengue virus (DV) infection is a major problem in public health. It can cause fatal diseases
such as Dengue hemorrhagic fever and Dengue shock syndrome. Dendritic cells (DC) are …

PURPOSE: To evaluate preoperative dendritic cell (DC) mobilization and tumor infiltration
after administration of Flt3 ligand (Flt3L) to patients with metastatic colon cancer. PATIENTS …

We studied the effects of administration of several cytokines, including progenipoietin-1
(ProGP-1), Flt-3 ligand (FL), granulocyte colony-stimulating factor (G-CSF), and granulocyte …

The effects of genetic adjuvants on humoral and cell-mediated immunity to two human
immunodeficiency virus antigens, Env and Nef, have been examined in mice. Despite …

Autoimmune diseases often result from inappropriate or unregulated activation of
autoreactive T cells. Traditional approaches to treatment of autoimmune diseases through …

Dendritic cells (DCs) show promise as adjuvants in anticancer immunotherapeutic
strategies. Flt3 ligand (FL) is a hematopoietic growth factor that increases the number of …